CAR T-cell trial offers promising second-line therapy for B-cell lymphoma

October 17, 2018 Providence News Team

Patients who have relapsed or failed first-line treatment for aggressive forms of B-cell non-Hodgkin lymphoma may qualify to receive a promising CAR T-cell therapy in a new clinical trial at Providence Cancer Institute:

Study: Lisocabtagene Maraleucel (JCAR017) as Second-Line Therapy (TRANSCEND-NHL-006) for B-cell non-Hodgkin lymphoma

JCAR017 is an investigational CAR T-cell therapy that modifies a patient’s own T-cells to express proteins called CARs (chimeric antigen receptors), which help T-cells recognize tumor cells and go after them. A Phase I study of JCAR017 in people with aggressive forms of B-cell lymphoma found that it provided “a durable reduction or eradication of cancer,” including complete cancer eradication in just over half of the patients. Read more in Lymphoma News Today.

CAR T-cell therapy is a major research priority for the Earle A. Chiles Research Institute, a division of Providence Cancer Institute in the Robert W. Franz Cancer Center. Read more about JCAR017 in Immuno-Oncology News, and find out more about adoptive T-cell therapy research at Providence.

Providence is one of only two centers in the United States currently participating in this clinical trial. For more information or to enroll a patient, call our Clinical Research office at 503-215-2614. Call us early for consideration, before the patient receives a salvage therapy or stem cell transplant.

See more studies
New research studies are added frequently. Please visit our website to see all studies in all cancer types currently open at Providence Cancer Institute.

Enter content here

About the Author

The Providence News Team brings you the updates to keep you informed about what's happening across the organizational ecosystem. From partnerships to new doctor announcements, we are committed to keeping you informed.
More Content by Providence News Team

Welcome to your journey for creating a healthier you

CAR T-cell trial offers promising second-line therapy for B-cell lymphoma

About the Author

Previous Article

Next Article

CAR T-cell trial offers promising second-line therapy for B-cell lymphoma

About the Author

Previous Article

Next Article

Most Recent Articles

Hospital named a “Best Hospital for Maternity Care” for exemplary programs for mom, baby

U.S. News & World Report has named Providence St. Joseph Hospital as a 2024 Maternity Care Access Hospital, an inaugural designation.

At the tender age of 104, Evo is recuperating after another hip surgery, this time a “redo” of his right hip back in September that he had done at St. Joseph Hospital in Eureka.

Helleland to serve dual role as chief executive of the Orange County/High Desert region in Providence’s newly restructured California South Division

A life-threatening experience turns into a life-changing moment.

AFib is one of the most common heart rhythm disorders, affecting millions of people in the U.S. alone.

A study for people with GI cancers and two studies for people with advanced and early-stage lung cancer hope to develop better treatment options with the help of immunotherapy.

Event to take place 5-7 p.m. on Tuesday, December 5 in the hospital’s front parking lot.

A new type of surgical treatment for patients with benign prostatic hyperplasia (BPH) uses the power of water delivered with robotic precision to provide long-lasting BPH relief

Providence honors the donors who have given the gift of life, health and hope to those in need.

Providence honors the donors who have given the gift of life, health and hope to those in need.

Providence honors the donors who have given the gift of life, health and hope to those in need.

Providence honors the donors who have given the gift of life, health and hope to those in need.

Hospital among 70 recipients committed to exceptional spine, neuroscience care

Meet Dr. Deron Ludwig, St. Patrick Hospital’s Bariatric Medical Director as he answers some important – and common – questions and offered insight for those considering surgery.

Providence Alaska provided $17,500 to help support the Kodiak Community Health Center’s MAT program, which since 2019 has been offering medical intervention for those struggling with drug addiction.

An injury or illness over the holiday season can present special challenges getting access to health care. Find out more about Providence's multiple care options.

Kadlec Regional Medical Center has been designated as a Heart Safe Campus by Richland Fire & Emergency Services.

New AVEIR™ DR Pacemaker is “like the difference between dial-up internet and high-speed Wi-Fi,” says surgeon

Providence Santa Rosa Memorial Hospital and Petaluma Valley Hospital announced today they have achieved numerous accolades for clinical excellence, according to new research released by Healthgrades.